Whether you are a company seeking funding or an investor considering an investment in the CGT space, DHC has the expertise to support your needs. Our most common offerings in the area of Diligence & Business Strategy (formerly known as Financing and Diligence) include:
We are frequently called upon by investors to perform due diligence on companies in the Cell and Gene Therapy space. Alternatively, for companies seeking investment, our mock diligence service can help ensure you are prepared for questions investors may raise.
Our knowledge of the Cell and Gene Therapy landscape can help you identify investment targets that are well-aligned with your portfolio objectives.
Are you an experienced investor who is new to the complex world of cell and gene? Or an existing pharma or biotech company that has recently acquired a cell and gene asset? We provide customized CGT teach-ins.
Our unique combination of deep technical expertise and investor relations experience allows us to provide a candid assessment of your program and strategic planning for an optimal ‘pitch.’